Diabetes Obesity and Metabolism,
Journal Year:
2020,
Volume and Issue:
23(S1), P. 50 - 62
Published: Sept. 24, 2020
Against
the
backdrop
of
obesity
as
a
major
public
health
problem,
we
examined
three
questions:
How
much
weight
loss
is
needed
to
benefit
patients
with
obesity?
well
do
current
therapies
in
producing
loss?
What
strategies
can
be
used
improve
patient
outcomes
using
evidence-based
studies.
This
paper
reviews
literature
on
lifestyle,
diet,
medications
and
surgical
treatments
for
searches
treatments.
Current
treatments,
including
diet
exercise,
produce
5%
7%
average.
Despite
continued
attempts
identify
superior
dietary
approaches,
most
careful
comparisons
find
that
low
carbohydrate
diets
are
not
significantly
better
than
fat
loss.
The
four
currently
approved
by
US
Food
Drug
Administration
long-term
management
effective
surgery,
adding
about
average
lifestyle
approaches
Two
new
under
investigation,
semaglutide
tirzepatide,
this.
For
all
loss,
there
enormous
variability
amount
lost.
Examination
this
has
yielded
evidence
supporting
baseline
process
predictors,
but
effect
sizes
associated
these
predictors
small
no
prospective
studies
showing
personalized
approach
based
genotype
or
phenotype
will
yield
uniform
success.
Because
chronic
disease
it
requires
'continuous
treatment
model'
across
lifespan.
Obesity Reviews,
Journal Year:
2019,
Volume and Issue:
20(5), P. 750 - 762
Published: Jan. 4, 2019
Summary
Lifestyle
interventions
addressing
diet,
exercise‐training,
sleep
hygiene,
and/or
tobacco/alcohol
cessation
are
recommended
in
the
management
of
obstructive
apnoea
(OSA).
Yet
their
effectiveness
on
this
condition
still
requires
further
research.
This
systematic
review
and
meta‐analysis
was
aimed
at
establishing
(a)
lifestyle
apnoea‐hypopnoea
index
(AHI),
oxygen
desaturation
(ODI),
excessive
daytime
sleepiness
(EDS),
secondary
OSA
measures
among
adults,
(b)
which
intervention
characteristics
may
drive
greatest
improvements.
A
search
studies
conducted
using
CINAHL,
ProQuest,
Psicodoc,
Scopus,
Web
Science,
from
inception
to
April
2018.
Standardized
mean
differences
were
calculated
inverse
variance
method
random‐effects
models.
The
meta‐analyses
13
randomized
controlled
trials
22
uncontrolled
before‐and‐after
(1420
participants)
revealed
significant
reductions
AHI
(
d
=
−0.61
−0.46,
respectively),
ODI
−0.46)
EDS
−0.41
−0.49).
Secondary
outcomes
also
improved
after
interventions.
However,
differed
depending
components,
severity,
gender.
Thus,
until
future
research
supports
differential
OSA,
those
weight
loss
through
diet
exercise‐training
be
most
effective
treatments
for
male
patients
with
moderate‐severe
OSA.
Proceedings of the National Academy of Sciences,
Journal Year:
2019,
Volume and Issue:
116(47), P. 23806 - 23812
Published: Nov. 4, 2019
Shift
work
causes
circadian
misalignment
and
is
a
risk
factor
for
obesity.
While
some
characteristics
of
the
human
system
energy
metabolism
differ
between
males
females,
little
known
about
whether
sex
modulates
effects
on
homeostasis.
Here
we
show-using
randomized
cross-over
design
with
two
8-d
laboratory
protocols
in
14
young
healthy
adults
(6
females)-that
has
sex-specific
influences
homeostasis
independent
behavioral/environmental
factors.
First,
affected
24-h
average
levels
satiety
hormone
leptin
sex-dependently
(P
<
0.0001),
∼7%
decrease
females
0.05)
an
∼11%
increase
0.0001).
Consistently,
also
increased
hunger
ghrelin
by
∼8%
during
wake
periods
without
significant
effect
males.
Females
reported
reduced
fullness,
consistent
their
appetite
changes.
However,
rise
cravings
energy-dense
savory
foods
not
homeostatic
hormonal
changes,
suggesting
involvement
hedonic
pathways
Moreover,
there
were
sex-dependent
respiratory
quotient
0.01),
significantly
values
0.01)
when
misaligned,
again
no
males,
expenditure.
Changes
sleep,
thermoregulation,
behavioral
activity,
lipids,
catecholamine
assessed.
These
findings
demonstrate
that
metabolism,
indicating
possible
mechanisms
countermeasures
obesity
male
female
shift
workers.
Obesity Reviews,
Journal Year:
2019,
Volume and Issue:
20(6), P. 795 - 804
Published: March 1, 2019
Summary
Obesity
is
a
worldwide
growing
problem.
When
confronted
with
obesity,
many
health
care
providers
focus
on
direct
treatment
of
the
consequences
adiposity.
We
plead
for
adequate
diagnostics
first,
followed
by
an
individualized
treatment.
provide
experience‐based
and
evidence‐based
practical
recommendations
(illustrated
clinical
examples),
to
detect
potential
underlying
diseases
contributing
factors.
Adult
patients
consulting
doctor
weight
gain
or
obesity
should
first
be
clinically
assessed
diseases,
such
as
monogenetic
syndromic
hypothyroidism,
(cyclic)
Cushing
syndrome,
polycystic
ovarian
syndrome
(PCOS),
hypogonadism,
growth
hormone
deficiency,
hypothalamic
obesity.
The
most
important
alarm
symptoms
genetic
are
early
onset
dysmorphic
features/congenital
malformations
without
intellectual
deficit,
behavioral
problems,
hyperphagia,
and/or
striking
family
history.
Importantly,
also
common
factors
investigated,
including
medication
(mainly
psychiatric
drugs,
(local)
corticosteroids,
insulin,
specific
β‐adrenergic
receptor
blockers),
sleeping
habits
quality,
crash
diets
yoyo‐effect,
smoking
cessation,
alcoholism.
Other
associated
conditions
include
mental
chronic
stress
binge‐eating
disorder
depression.Identifying
optimizing
factors,
other
may
not
only
result
in
more
effective
personalized
but
could
reduce
social
stigma
Nature and Science of Sleep,
Journal Year:
2018,
Volume and Issue:
Volume 10, P. 45 - 64
Published: Jan. 31, 2018
Polycystic
ovary
syndrome
(PCOS)
is
a
complex
endocrine
disorder
affecting
the
reproductive,
metabolic
and
psychological
health
of
women.
Clinic-based
studies
indicate
that
sleep
disturbances
disorders
including
obstructive
apnea
excessive
daytime
sleepiness
occur
more
frequently
among
women
with
PCOS
compared
to
comparison
groups
without
syndrome.
Evidence
from
few
available
population-based
supportive.
Women
tend
be
overweight/obese,
but
this
only
partly
accounts
for
their
problems
as
associations
are
generally
upheld
after
adjustment
body
mass
index;
also
in
normal
weight.
There
several,
possibly
bidirectional,
pathways
through
which
associated
disturbances.
The
pathophysiology
involves
hyperandrogenemia,
form
insulin
resistance
unique
affected
women,
possible
changes
cortisol
melatonin
secretion,
arguably
reflecting
altered
hypothalamic-pituitary-adrenal
function.
Psychological
behavioral
likely
play
role,
anxiety
depression,
smoking,
alcohol
use
lack
physical
activity
common
PCOS,
response
distressing
symptoms
they
experience.
specific
impact
on
not
yet
clear;
however,
both
deterioration
cardiometabolic
longer
term
increased
risk
type
2
diabetes.
Both
immediate
quality
life
longer-term
benefit
diagnosis
management
part
interdisciplinary
care.
Diabetes Obesity and Metabolism,
Journal Year:
2020,
Volume and Issue:
23(S1), P. 50 - 62
Published: Sept. 24, 2020
Against
the
backdrop
of
obesity
as
a
major
public
health
problem,
we
examined
three
questions:
How
much
weight
loss
is
needed
to
benefit
patients
with
obesity?
well
do
current
therapies
in
producing
loss?
What
strategies
can
be
used
improve
patient
outcomes
using
evidence-based
studies.
This
paper
reviews
literature
on
lifestyle,
diet,
medications
and
surgical
treatments
for
searches
treatments.
Current
treatments,
including
diet
exercise,
produce
5%
7%
average.
Despite
continued
attempts
identify
superior
dietary
approaches,
most
careful
comparisons
find
that
low
carbohydrate
diets
are
not
significantly
better
than
fat
loss.
The
four
currently
approved
by
US
Food
Drug
Administration
long-term
management
effective
surgery,
adding
about
average
lifestyle
approaches
Two
new
under
investigation,
semaglutide
tirzepatide,
this.
For
all
loss,
there
enormous
variability
amount
lost.
Examination
this
has
yielded
evidence
supporting
baseline
process
predictors,
but
effect
sizes
associated
these
predictors
small
no
prospective
studies
showing
personalized
approach
based
genotype
or
phenotype
will
yield
uniform
success.
Because
chronic
disease
it
requires
'continuous
treatment
model'
across
lifespan.